Assignee profile:

LFB BIOTECHNOLOGIES

City:

Les Ulis

Country:

France

Published Applications:

40

Last publication date:

2014-04-03

Patent Grants:

21

Last grant date:

2019-07-30

Top Inventors for applications by LFB BIOTECHNOLOGIES

These are the the leading inventors for applications assigned to LFB BIOTECHNOLOGIES:

Recent patent applications by LFB BIOTECHNOLOGIES

LFB BIOTECHNOLOGIES based in Les Ulis, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-04-03 ✅ Patent 10,364,425 granted on 2019-07-30
US20140093491A1
Chemistry; metallurgy

Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units

#2 | 2013-12-26 ✅ Patent 9,803,184 granted on 2017-10-31
US20130344567A1
Chemistry; metallurgy

Method for immobilizing nucleic ligands

#3 | 2013-07-25
US20130189244A1
Chemistry; metallurgy

RECOMBINANT OR TRANSGENIC FACTOR VII COMPOUND HAVING A MAJORITY OF GLYCAN, BIANTENNARY, BISIALYLATED AND NON-FUCOSYLATED FORMS

#4 | 2013-06-06 ✅ Patent 9,359,610 granted on 2016-06-07
US20130143302A1
Chemistry; metallurgy

Method for purifying GLA-domain coagulation proteins

#5 | 2013-05-30 ✅ Patent 9,012,607 granted on 2015-04-21
US20130136743A1
Chemistry; metallurgy

Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II

#6 | 2012-10-25 ✅ Patent 9,212,365 granted on 2015-12-15
US20120271039A1
Chemistry; metallurgy

Method for purifying active GLA-domain coagulation proteins

#7 | 2012-10-11 ✅ Patent 8,357,370 granted on 2013-01-22
US20120258096A1
Chemistry; metallurgy

Anti-D monoclonal antibodies

#8 | 2012-05-17 ✅ Patent 9,534,012 granted on 2017-01-03
US20120122179A1
Chemistry; metallurgy

Affinity substrate and methods for selectively purifying a blood plasma protein

#9 | 2012-04-26
US20120100133A1
Chemistry; metallurgy

USE OF ANTI-CD20 ANTIBODY FOR TREATING PRIMARY INTRAOCULAR LYMPHOMA

#10 | 2012-04-12 ✅ Patent 9,029,316 granted on 2015-05-12
US20120087908A1
Human necessities

Factor VII composition

#11 | 2012-02-16
US20120041056A1
Chemistry; metallurgy

NUCLEIC ACIDS SPECIFICALLY BINDING WITH HUMAN FACTOR VII/VIIA AND USES THEREOF

#12 | 2012-02-16
US20120040905A1
Chemistry; metallurgy

MEANS FOR PURIFYING A COAGULATION PROTEIN, AND METHODS FOR IMPLEMENTING SAME

#13 | 2012-01-12 ✅ Patent 8,742,074 granted on 2014-06-03
US20120009188A1
Chemistry; metallurgy

Optimized FC variants

#14 | 2011-12-22 ✅ Patent 8,404,241 granted on 2013-03-26
US20110311556A1
Chemistry; metallurgy

Anti-rhesus D monoclonal antibody

#15 | 2011-11-10
US20110274684A1
Chemistry; metallurgy

CYTOTOXIC ANTIBODIES DIRECTED AGAINST ANTIBODIES INHIBITING FACTOR VIII

#16 | 2011-10-13
US20110250702A1
Chemistry; metallurgy

ISOLATED PEPTIDES OF RABBIT FACTOR VII

#17 | 2011-08-18 ✅ Patent 9,012,608 granted on 2015-04-21
US20110201033A1
Chemistry; metallurgy

G immunoglobulin used against anthrax toxins

#18 | 2011-07-07
US20110165613A1
Physics

STABLE CLONE CELL EXPRESSING A PRION

#19 | 2011-06-30
US20110162094A1
Human necessities

MODIFIED HUMAN FACTOR VII/VIIA AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

#20 | 2011-06-23
US20110151476A1
Physics

METHOD OF DETECTION AND/OR TITRATION IN VITRO OF AN UNCONVENTIONAL TRANSMISSIBLE AGENT

#21 | 2011-04-28
US20110097754A1
Physics

METHOD FOR MEASURING ACTIVATED FACTOR VII LEVEL IN A SAMPLE

#22 | 2011-04-28 ✅ Patent 9,175,034 granted on 2015-11-03
US20110097715A1
Chemistry; metallurgy

Method for purifying or detecting a target protein

#23 | 2011-03-10 ✅ Patent 8,178,093 granted on 2012-05-15
US20110059073A1
Chemistry; metallurgy

Method for treating infectious disease using monoclonal antibodies

#24 | 2011-03-10 ✅ Patent 8,153,124 granted on 2012-04-10
US20110059072A1
Chemistry; metallurgy

Method for treating cancer using monoclonal antibodies

#25 | 2011-03-03 ✅ Patent 8,124,078 granted on 2012-02-28
US20110052571A1
Chemistry; metallurgy

Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies

#26 | 2010-12-02
US20100305305A1
Chemistry; metallurgy

METHOD FOR PURIFYING FACTOR VIII AND VON WILLEBRAND FACTOR

#27 | 2010-08-05 ✅ Patent 8,802,620 granted on 2014-08-12
US20100197578A1
Chemistry; metallurgy

Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A

#28 | 2010-08-05 ✅ Patent 8,025,803 granted on 2011-09-27
US20100193440A1
Chemistry; metallurgy

Use of a chromatography substrate for reducing the amount of ADAMTS13 in a solution derived from plasma

#29 | 2010-06-10
US20100143370A1
Chemistry; metallurgy

SET OF MEANS FOR TREATING A MALIGNANT PATHOLOGY, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE

#30 | 2010-04-22
US20100098706A1
Chemistry; metallurgy

MONOCLONAL ANTIBODY DIRECTED AGAINST THE HUMAN LDL RECEPTOR

#31 | 2010-02-25
US20100047428A1
Chemistry; metallurgy

METHOD FOR THE EXTRACTION OF ONE OR SEVERAL PROTEINS IN MILK

#32 | 2009-12-24
US20090317373A1
Chemistry; metallurgy

Inhibition of the Anti-FVIII Immune Response

#33 | 2009-12-17 ✅ Patent 10,344,272 granted on 2019-07-09
US20090311239A1
Chemistry; metallurgy

Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units

#34 | 2009-11-12 ✅ Patent 8,492,524 granted on 2013-07-23
US20090281283A1
Chemistry; metallurgy

Method for extracting a protein from milk

#35 | 2009-09-24
US20090239788A1
Chemistry; metallurgy

RECOMBINANT OR TRANSGENIC FACTOR VII COMPOUND HAVING A MAJORITY OF GLYCAN, BIANTENNARY, BISIALYLATED AND NON-FUCOSYLATED FORMS

#36 | 2009-07-09
US20090176220A1
Chemistry; metallurgy

ANTIBODY CHARACTERIZATION TEST

#37 | 2009-07-09
US20090175789A1
Chemistry; metallurgy

Antibody raised against the ldl receptor

#38 | 2009-05-21 ✅ Patent 8,038,993 granted on 2011-10-18
US20090130094A1
Chemistry; metallurgy

Cytotoxic antibodies directed against antibodies inhibiting factor VIII

#39 | 2009-01-29
US20090029393A1
Chemistry; metallurgy

METHOD FOR PREPARING ANTIBODIES SELECTIVE FOR ACTIVATING FC RECEPTORS

#40 | 2005-11-10 ✅ Patent 7,931,895 granted on 2011-04-26
US20050249722A1
Chemistry; metallurgy

Monoclonal antibodies with enhanced ADCC function

Also check out LFB BIOTECHNOLOGIES's (Les Ulis, France) applicant profile with 2 patent applications submitted.

AssigneeID:

25218 ⎘